Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents

Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents

Abstract Background Autologous haematopoietic stem cell transplantation (AHSCT) is more effective than conventional immunosuppressive therapies (CIT) in improving the outcome of patients with rapidly progressive diffuse cutaneous systemic sclerosis (dcSSc). So far, there is still a paucity of data c...

Full description

Bibliographic Details
Main Authors: Nicoletta Del Papa, Silvia Cavalli, Andrea Rindone, Francesco Onida, Giorgia Saporiti, Antonina Minniti, Maria Rosa Pellico, Claudia Iannone, Giorgia Trignani, Nicoletta D’Angelo, Manuel Sette, Raffaella Greco, Claudio Vitali, Roberto Caporali
Format: Article
Language:English
Published: BMC 2024-10-01
Series:Arthritis Research & Therapy
Subjects:
Autologous haematopoietic stem cell transplantation
Systemic sclerosis
Rituximab
Immunosuppressive therapy
Online Access:https://doi.org/10.1186/s13075-024-03408-4

Internet

https://doi.org/10.1186/s13075-024-03408-4

Similar Items